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Abstract
Background: Balance dysfunction and falls are common problems in later stages of dementia.
Exercise is a well-established intervention to reduce falls in cognitively intact older people, although
there is limited randomised trial evidence of outcomes in people with dementia. The primary
objective of this study is to evaluate whether a home-based balance exercise programme improves
balance performance in people with mild to moderate severity Alzheimer's disease.
Methods/design:  Two hundred and fourteen community dwelling participants with mild to
moderate severity Alzheimer's disease will be recruited for the randomised controlled trial. A
series of laboratory and clinical measures will be used to evaluate balance and mobility performance
at baseline. Participants will then be randomized to receive either a balance training home exercise
programme (intervention group) from a physiotherapist, or an education, information and support
programme from an occupational therapist (control group). Both groups will have six home visits
in the six months following baseline assessment, as well as phone support. All participants will be
re-assessed at the completion of the programme (after six months), and again in a further six
months to evaluate sustainability of outcomes. The primary outcome measures will be the Limits
of Stability (a force platform measure of balance) and the Step Test (a clinical measure of balance).
Secondary outcomes include other balance and mobility measures, number of falls and falls risk
measures, cognitive and behavioural measures, and carer burden and quality of life measures.
Assessors will be blind to group allocation.
Longitudinal change in balance performance will be evaluated in a sub-study, in which the first 64
participants of the control group with mild to moderate severity Alzheimer's disease, and 64 age
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and gender matched healthy participants will be re-assessed on all measures at initial assessment,
and then at 6, 12, 18 and 24 months.
Discussion: By introducing a balance programme at an early stage of the dementia pathway, when
participants are more likely capable of safe and active participation in balance training, there is
potential that balance performance will be improved as dementia progresses, which may reduce
the high falls risk at this later stage. If successful, this approach has the potential for widespread
application through community based services for people with mild to moderate severity
Alzheimer's disease.
Trial registration: The protocol for this study is registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12608000040369).
Background
Dementia is a major worldwide health problem among
older people. It is one of the most burdensome condi-
tions, and is a leading cause of disability and mortality in
later life [1]. The prevalence of dementia is estimated to be
1.5% of people aged 65 years, and prevalence becomes
more common with increasing age, reaching a level of
22% in people older than 85 years [2]. The global preva-
lence of dementia is forecast to double every 20 years, to
42.3 million in 2020 and to 81.1 million people in 2040
[3]. It is estimated that there will be more than one mil-
lion people with dementia in the UK by 2025 [4]. The
number of people with dementia is expected to triple in
the United States by 2040 [5], and in Australia by 2050
[6]. Alzheimer's disease is the most common type of
dementia, accounting for 50–70% of all dementias [7,8].
Falls are another major public health issue for the older
population, with 30% percent of people aged 65 and over
falling once or more each year [9,10]. Even higher falls
rates have been reported for people with dementia, with
around 42% of a community sample with mild-moderate
dementia, and 60% of people with dementia in residen-
tial care falling at least once each year [11,12]. Decrease in
balance performance is a strong indicator of falls in older
people [13,14]. Greater balance and gait disturbances
have been found in people with dementia when com-
pared with older people in general [15,16], and these have
been shown to occur in relatively early stages of the
dementia pathway [17]. These declines in balance and
motor performance may explain the increased incidence
of falls in people with dementia, and have been shown to
be a predictive factor for people with dementia needing
permanent skilled nursing facility admission [18].
Increased carer strain has also been reported following a
fall by care recipients [19].
There has been growing interest in the potential for
improved outcomes associated with general exercise for
people with cognitive impairment or dementia [20,21],
and a number of different exercise approaches have been
trialled. Exercise programmes targeting balance perform-
ance have been shown to improve balance and reduce
falls in a range of community dwelling samples of older
people [22-24], but none of these have included people
with dementia [25]. While exercise programmes have
been shown to be feasible for people with dementia
[26,27], even at relatively advanced stages [28,29], these
programmes usually primarily incorporate cardiovascular
type exercises such as walking (or simple exercises for
strengthening and flexibility). To reduce falls in older peo-
ple, exercise programmes need to safely incorporate a
challenge to the balance system [22-24], which requires
substantially more complex movement combinations
than cardiovascular or strength training exercise pro-
grammes. People with dementia are less likely to be able
to successfully participate in these more complex move-
ments at later stages of disease progression. Therefore,
there is merit in exploring the feasibility and outcomes of
balance training exercise programmes for people with
mild to moderate severity dementia. Studies in older peo-
ple living in the community who do not have dementia
have demonstrated that improved balance performance
from a balance exercise programme can be maintained for
periods up to two years [30]. By introducing a balance
training programme for people at mild to moderate levels
of severity of dementia, it is anticipated that improved
balance related outcomes may similarly persist well
beyond the period of active engagement in the formal
exercise programme. It is also possible that if this type of
exercise programme becomes part of routines in earlier
stages of the dementia pathway, that these exercises might
be able to be continued as dementia progresses, rather
than trying to introduce new tasks at later stages.
Given the high proportion of people with dementia who
have a diagnosis of Alzheimer's disease, and varying
symptoms and progression between people with different
types of dementia [31], this study will focus recruitment
on people with a diagnosis of Alzheimer's disease. To
date, no study has evaluated a balance exercise pro-
gramme designed to improve balance performance, spe-BMC Geriatrics 2009, 9:29 http://www.biomedcentral.com/1471-2318/9/29
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cifically targeting community dwelling people with mild
to moderate Alzheimer's disease.
The primary aim of the present project is to implement
and evaluate the effectiveness of an individually tailored,
home based exercise programme in improving balance
and mobility performance in people with mild to moder-
ate severity Alzheimer's disease. A sub-study will be run
concurrently, with the aim of evaluating difference in rate
of change in balance performance between people with
Alzheimer's disease compared to healthy age and gender
matched older people.
Methods/design
Study Design
The primary study is a single blind Randomised Control-
led Trial (Figure 1). The CONSORT statement has been
used as a framework for development of the methodology
for this project. The sub-study is a longitudinal cohort
study.
Participants Criteria
Participants with Alzheimer's disease
Participants will be included in the primary study if they
have all of the following criteria: (i) a diagnosis of Alzhe-
imer's disease; (ii) mild to moderate dementia (Clinical
Dementia Rating Scale score of 0.5–2.0) [32]; (iii) inde-
pendent mobility (walks outdoors with no more support
than a single point stick); (iv) living in the community (ie
not living in residential care); and (v) no other major neu-
rological history (e.g. stroke with unilateral or bilateral
paresis, multiple sclerosis) or orthopaedic history that
impacts on functional mobility.
Participants will be excluded if they have a dementia diag-
nosis other than Alzheimer's disease; severe dementia (a
Clinical Dementia Rating Scale of more than 2.0), limited
Study design Figure 1
Study design.
	

		



	

	
	



				
	
		
	


				
		
 !	"
	#
$
	
 
 		


%
	
&
'


	

	


&
'








	
(	
		'

'









)

	

)#

 	


	

&
'

#
&
'

#
*



		

(

+
	

		
 

,

	
 

 
		
#
&
'

-# 
BMC Geriatrics 2009, 9:29 http://www.biomedcentral.com/1471-2318/9/29
Page 4 of 9
(page number not for citation purposes)
mobility (doesn't walk away from home, or needs more
support than a single point stick to walk outdoors); or
presence of clinically significant aphasia (patient needs to
be able to understand instructions in the exercise arm of
the intervention).
Diagnosis of Alzheimer's disease will be confirmed
through records from specialist Memory Clinics or by the
treating general practitioner. Memory Clinics are multi-
disciplinary services established to provide early diagnosis
and service provision information for patients with cogni-
tive impairment and dementia and their families [33].
Healthy group (longitudinal sub-study)
Sixty-four healthy participants, age and gender matched to
the first 64 people with Alzheimer's disease in the control
group of the primary study, will be recruited from com-
munity advertisements such as newsletters and existing
volunteer databases (ie the National Ageing Research
Institute database). These participants will have no cogni-
tive impairment (MMSE score ≥ 24) and no serious neu-
rological or orthopaedic condition that impacts on
balance and mobility performance, and will be commu-
nity ambulant (regularly walks independently away from
home).
Measurements and Procedures
At baseline and at subsequent assessment occasions (Fig-
ure 1), the following measures will be used:
Measures of cognitive impairment and behavioural disturbances 
include
(i) Mini Mental State Examination (MMSE) [34], a widely
used instrument for screening cognitive impairment. It
comprises 11 items covering orientation, registration,
attention and calculation, recall, language, a 3 step praxis
item, and graphic copy of a geometric design.
(ii) Frontal Assessment Battery (FAB) [35], a short cogni-
tive and behavioural battery to assess frontal lobe func-
tions. The FAB consists of 6 subtests exploring
conceptualization, mental flexibility, motor program-
ming, sensitivity to interference, inhibitory control, and
environmental autonomy. This test has been shown to
distinguish frontotemporal dementia from Alzheimer's
dementia [36].
(iii) Neuropsychiatric Inventory (NPI) [37], a screening
questionnaire to assess 10 behavioural disturbances
occurring in people with dementia, including delusions,
hallucinations, agitation/aggression, dysphoria, anxiety,
euphoria, apathy, disinhibition, irritability/lability, and
aberrant motor activity. The NPI will be obtained from a
caregiver familiar with the participant's behaviour.
Measures of balance and mobility performance
The following laboratory measures from the NeuroCom
Balance Master™ long plate (NeuroCom Balance Master™
Operator V3: CopyRight©2007) will be used:
(i) Modified Clinical Test of Sensory Interaction of Bal-
ance (mCTSIB), the amount of postural sway is measured
under four sensory conditions (eyes open and eyes closed,
on a firm and a foam surface); (ii) Limits of Stability
(LOS), a measure of the ability to weight shift forwards,
backwards, to the right and the left in standing; (iii) stabil-
ity during walking and turning; and (iv) stability during
sit to stand. This test battery has been shown to have mod-
erate to high test-retest reliability in assessing balance dys-
function in healthy older people [38] and clinical groups
(eg stroke, Limits of Stability measures, ICC>0.84) [39]
and to be sensitive to be able identify patients who have
fallen and to be able to predict multiple falls [40].
A number of clinical measures of balance and mobility
will also be used. These measures are simple and quick
tests routinely used in clinical practice and research:
(i) Functional Reach (FR) test [41], a test of dynamic
standing balance. The participant stands next to a wall
with their feet 10 cm apart and dominant arm raised to 90
degrees. They are then asked to reach as far forward as pos-
sible without overbalancing and the distance of addi-
tional reach is recorded (cm).
(ii) Step Test [42], a test of dynamic standing balance. The
number of times the participant steps one foot fully on
and then off a 7.5 cm block step in 15 seconds is recorded.
Each leg is tested separately, and worst side performance
will be used for data analysis.
(iii) Timed Chair Stands [43]- global leg muscle strength
will be measured by timing speed of standing up/sitting
down five times from a 45 cm high chair, without using
arms.
(iv) Timed Up and Go (TUG) test [44]-the participant is
timed standing up from a standard chair, walking 3
metres with their usual speed, then returning to sit again
in the chair (seconds). This task will be reassessed under
dual task conditions, with a secondary cognitive task
(counting backwards by 3's while performing the TUG),
and with a secondary motor task (carrying a full cup of
water while performing the TUG) [45].
Measures of falls and falls risk include
(i) the number of falls in the preceding 12 months will be
collected from the participant or carer, based on retrospec-
tive recall; (ii) the Falls Risk for Older People (FROP-
Com) [46], a detailed falls risk assessment tool evaluatingBMC Geriatrics 2009, 9:29 http://www.biomedcentral.com/1471-2318/9/29
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13 risk factors; and (iii) Physiological Profile Assessment
(PPA) [47] abbreviated assessment, evaluating standing
balance, hand reaction time, knee joint proprioception,
visual contrast sensitivity and quadriceps muscle strength.
The FROP-Com and the PPA have been shown to have
good retest reliability (FROP-Com intra-rater and inter-
tester reliability were 0.93 and 0.81 respectively, and the
PPA retest reliability ranged from 0.50 to 0.97), and the
FROP-Com to have moderate capacity to predict falls
(sensitivity 71% and specificity 56%) [46,47].
Caregiver burden and quality of life will be assessed using
(i) the Zarit Carer Burden Scale [48]; and (ii) the Assess-
ment of Quality of Life (AQoL) [49].
Randomization
After baseline assessment, participants will be randomly
allocated into the exercise or control groups. Randomiza-
tion will be by computer generated random numbers
table, with group allocation on a folded piece of paper in
an opaque envelope, packed by a staff member independ-
ent of the project team. A research assistant independent
of the assessors will identify group allocation, and com-
municate with the participant and their carer as to which
group they are in, and make arrangements for the next
stage of the project. In this way, assessors will be blind to
the group allocation-randomization process at the time of
the baseline assessment.
Intervention Group and Control Group Activities
The control group will continue with "usual care" for the
subsequent six months without interruption, including all
activities and service use recommended by treating health
professionals. In addition, participants in the control
group will receive a home programme involving six home
visits for the six month period by an Occupational Thera-
pist, to provide an information/education and support
programme. Topics to be covered in the programme
include issues around diagnosis; community services;
occupational performance (including issues around grief
and losses); and environmental safety and aids. The pro-
gramme will avoid any messages encouraging any change
in activities that may influence balance and mobility per-
formance. Control participants will receive phone calls
from the Occupational Therapist to follow up on issues
raised in the home visits between home visits.
The intervention group will participate in a tailored
(individualised) home based balance exercise pro-
gramme, provided by a physiotherapist. This exercise pro-
gramme is based on an existing home exercise programme
(the Otago programme, http://www.acc.co.nz/prevent
ing-injuries/at-home/older-people/information-for-
older-people/otago-exercise-programme/index.htm),
which has been shown to improve balance and reduce
falls in older people without cognitive impairment in the
community setting [50-52]. The programme has been
modified to provide increased support and visits in the
early stages of exercising. Appropriate exercises from the
Otago programme will be selected by the physiotherapist,
and be tailored to balance and mobility problems identi-
fied from the assessments. Participants will receive six
home visits during the six month duration (two visits in
the first month after the baseline assessment, two further
visits in the second month, then two more home visits
four to six weeks apart for the remaining times). An exer-
cise booklet will be provided by the physiotherapist to
each participant or carer to give illustrations and instruc-
tions for the participant to continue the exercise pro-
gramme at least five times a week. In between visits, the
physiotherapist will contact participants by telephone
(five phone calls during the six month duration). Adher-
ence to the programme will be monitored by daily com-
pletion of an exercise diary. All participants will also
continue to receive 'usual care'.
Follow Up Assessments
Six months after the initial assessment all participants will
have all baseline measures repeated by an assessor blind
to group allocation. Measures will be repeated six months
later (ie 12 months after initial assessment) to determine
sustained benefits from the programme.
Focus Groups
A randomly selected sub-sample of 20 participants from
the exercise programme and their caregivers will be
invited to participate in focus groups to discuss issues
about falls, balance problems, positive and negative
aspects of the exercise programme, and other relevant fac-
tors influencing participation and outcomes. Data from
the focus groups will be recorded, transcribed, and the-
matically analysed to provide qualitative data informing
future recommendations.
Safety
All assessments will be undertaken by an experienced
physiotherapist, providing close supervision during all
tasks. In addition, a safety harness will be used for several
of the NeuroCom Balance Master™ assessments, which
will allow the participant freedom of movement to elicit
balance reactions, but will prevent them from falling in
the case of overbalancing. The home exercise programme
is based on a home exercise programme that has been
shown in a number of studies of older people with
increased falls risk to be safely implemented, and to
reduce falls [50,52]. The frequency of home visits in this
study is slightly increased on the successful "Otago" pro-
gramme (4 visits), aiming to maximise safety with
increased visits particularly in the first 6–8 weeks of the
programme. The personalized balance exercise pro-BMC Geriatrics 2009, 9:29 http://www.biomedcentral.com/1471-2318/9/29
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gramme will be tailored to each individual by an experi-
enced physiotherapist. The exercise prescription and
implementation will take into account participant safety.
Ethical Considerations
Participants will be reassured that their decision as to
whether or not they participate in the study is voluntary,
and that participation will not influence their usual treat-
ment. Written informed consent will be obtained. If the
person with Alzheimer's disease is unable to provide
informed consent (as determined by CDAMS records or
general practitioner records) to participate (or to continue
participation), their next of kin or their caregivers (person
responsible) will be asked to provide written consent. The
name and contact details of all participants and any infor-
mation obtained in connection with this research that can
identify individual participants will remain confidential
and will be used only for the purpose of the research. In
any publication, information will be provided in such a
way that no individual participant can be identified. All
records collected for this research will be kept in a secure
place. All records will be archived and retained for a min-
imum of seven years according to the ethics protocol. At
the end of this period, paper-based records will be shred-
ded, and electronically stored data will be erased.
Ethics approval has been obtained from the Melbourne
Health Human Research Ethics Committees (HREC
2008.004/Approval Date: 16-Apr-08), and the University
Human Ethics Committee, La Trobe University (Applica-
tion No. 08-011/Approval Date: 30-Jul-08).
Primary Outcome Measures
Two primary outcome measures have been selected: Lim-
its of Stability (LOS) test (Maximum Excursion measure)
(Neurocom Balance Master™) and the Step Test. All other
measures will be considered as secondary outcomes. The
LOS Maximum Excursion measure is a dynamic balance
measure which has been shown to be a sensitive measure
of balance impairment, and to be responsive to exercise
interventions in older populations [38,40,53]. The Step
Test is a simple clinical balance measure which is rou-
tinely used in clinical practice and research in the field of
balance and falls prevention. It has high reliability [42]
and is sensitive to change in balance performance in older
people with clinical conditions such as Parkinson's dis-
ease [54,55] and stroke patients [42,56], and is responsive
to change following an exercise intervention [57].
Sub-study – Longitudinal Change in Balance Performance
The first 64 participants recruited for the primary study
and randomised to the control group will undergo com-
plete assessments as described in the primary study, but
also have further complete assessments at 18 months and
24 months following the initial assessment. Sixty four age
and gender matched healthy participants will also be
assessed on the full balance assessment battery at 0, 6, 12,
18 and 24 months for comparison of the rate of change in
balance performance in the sample with mild to moderate
severity Alzheimer's disease.
Statistical Analysis
Intention to treat analysis will be used. Balance perform-
ance on the two primary outcome measures and the sec-
ondary outcome measures will be made using repeated
measures ANOVA between the two groups, with variables
differing between groups at baseline being used as covari-
ates. Multivariate logistic regression will be used to evalu-
ate factors associated with improved outcomes, including
level of adherence to the exercise programme. For the lon-
gitudinal sub-study, independent sample t-tests will be
used to determine differences in balance performance
between both groups at each time point.
Sample Size
Power analysis was based on data from a recent study of
community dwelling older people with mild balance
impairment (approximately 15–25% impairment com-
pared to healthy controls), which is in the approximate
range of impairment anticipated in our sample with mild-
moderate severity Alzheimer's disease. Using data from
one of the main force platform measures of balance (Lim-
its of Stability, Maximum Excursion, mean score 71.9; SD
14.3) and a clinical balance measure (Step Test, mean
score 14, SD 3.6), power calculations were performed to
determine the required sample size to demonstrate a 10%
improvement, at 80% power and alpha = 0.05. Using
these two tests as primary outcome measures for evaluat-
ing the effectiveness of the balance retraining exercise pro-
gramme, a sample size of 80 per group will be required
(160 overall). Assuming a loss to follow up of 25%, a sam-
ple of 214 will be required for the main study (RCT
study). For the longitudinal sub-study, based on the esti-
mated magnitude of balance impairment (15–25%) rela-
tive to healthy age matched controls from previous
studies, a sample size of 42 will be sufficient to demon-
strate group differences (healthy vs Alzheimer's disease
group) on the Limits of Stability Maximum Excursion out-
come. Allowing for 20% dropout in this group/year over
the 2 year follow-up period for this group, 64 healthy age
and gender matched controls (matched to the first 64 par-
ticipants in the control group) will be required for the lon-
gitudinal follow-up component of the study. This sample
size will be sufficient to identify significant decline in per-
formance over a two year follow-up period (power 0.8,
alpha 0.05, single sided analysis, assuming 7% decline in
balance performance/year in the Alzheimer's disease
group). Previous studies have shown a change of 1–2%
per year on balance and mobility measures for healthy
older people [58], and over 10% decline in Activities ofBMC Geriatrics 2009, 9:29 http://www.biomedcentral.com/1471-2318/9/29
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Daily Living (including locomotion) in six months in
people with moderate severity dementia [59].
Missing data
To evaluate participant dropout bias, testing for missing at
random (MAR) data will be performed. If the missing val-
ues are missing at random, the procedures of maximum
likelihood (ML) [60] and multiple imputation (MI) [61]
will be used for intention-to-treat analyses. In addition,
the results from these two intention-to-treat analysis will
be compared, as well as the results analyzed with dropped
data to determine what difference the three approaches
may cause.
Discussion
Considerable research evidence exists to suggest that a
range of single and multiple falls prevention interventions
may reduce falls in the community setting [25,62], and
exercise is considered to be an effective and essential part
of fall prevention programmes [22,23]. In addition, a
recent meta-analysis of almost 50 randomised trials inves-
tigating exercise interventions to reduce falls in older peo-
ple has concluded that a focus on balance and lower
muscle strength training are key contributing factors to
the success of exercise interventions [24]. Despite cogni-
tive impairment being an independent risk factor for falls,
most community-based falls prevention studies have
excluded participants with cognitive impairments such as
Alzheimer's disease. In the few studies that have included
participants with Alzheimer's disease, the focus has been
on problems of balance impairment, falls and falls inju-
ries at later stages of disease progression, or among those
with Alzheimer's disease living in residential facilities
[63]. A clear gap in the current research relates to whether
there is potential to implement a balance exercise pro-
gramme at the earlier stages of the disease process in com-
munity dwelling people with Alzheimer's disease –
particularly when these people still have capacity to safely
and actively engage in this type of intervention.
Given (i) the high risk of falls associated with advanced
Alzheimer's disease, (ii) the negative impact of balance
problems and falls on ongoing care within the home envi-
ronment, and (iii) the increased risk of hospitalisation or
admission to a residential care facility after a fall, this
project has the potential for wide applicability within this
target group. Specifically, if it could be shown that balance
can be maintained or improved at the earlier stages of
Alzheimer's disease, this improved balance capacity may
possibly reduce fall risks at later stages of the dementia
pathway. Furthermore, from a health service perspective,
if the approach in the proposed study were successful, it
would support a case for balance screening and the provi-
sion of a balance training exercise programme as a routine
component of early management for people diagnosed
with Alzheimer's disease. Finally, delaying onset of bal-
ance dysfunction by several years may also have an effect
of reducing disability-adjusted life years lost associated
with Alzheimer's disease.
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